Zoetis (ZTS)
(Delayed Data from NYSE)
$158.42 USD
+5.06 (3.30%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $158.42 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
Price, Consensus and EPS Surprise
ZTS 158.42 +5.06(3.30%)
Will ZTS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ZTS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ZTS
Wall Street Analysts Look Bullish on Zoetis (ZTS): Should You Buy?
Zoetis (ZTS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ZTS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts
Zoetis (ZTS) Stock Moves -0.14%: What You Should Know
Other News for ZTS
The spread of avian flu to cattle could have implications for some stocks
Zoetis Foundation Champions Global Veterinarian Education, Well-being, and Livelihoods on World Veterinary Day and Beyond
Zoetis Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
ZTS August 16th Options Begin Trading
Baron Health Care Fund Q1 2024 Shareholder Letter